2.74
price down icon9.27%   -0.28
after-market Dopo l'orario di chiusura: 2.74
loading
Precedente Chiudi:
$3.02
Aprire:
$2.91
Volume 24 ore:
775.60K
Relative Volume:
1.41
Capitalizzazione di mercato:
$165.87M
Reddito:
-
Utile/perdita netta:
$-69.31M
Rapporto P/E:
-2.1575
EPS:
-1.27
Flusso di cassa netto:
$-62.80M
1 W Prestazione:
-6.16%
1M Prestazione:
-33.82%
6M Prestazione:
-44.08%
1 anno Prestazione:
+15.13%
Intervallo 1D:
Value
$2.71
$2.97
Intervallo di 1 settimana:
Value
$2.71
$3.065
Portata 52W:
Value
$2.2216
$6.1856

Rezolute Inc Stock (RZLT) Company Profile

Name
Nome
Rezolute Inc
Name
Telefono
650-206-4507
Name
Indirizzo
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-11
Name
Ultimi documenti SEC
Name
RZLT's Discussions on Twitter

Confronta RZLT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RZLT
Rezolute Inc
2.74 165.87M 0 -69.31M -62.80M -1.27
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Rezolute Inc Stock (RZLT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-05 Iniziato Wedbush Outperform
2024-08-27 Iniziato Guggenheim Buy
2024-07-17 Iniziato BTIG Research Buy
2024-06-04 Iniziato Craig Hallum Buy
2024-04-09 Iniziato Maxim Group Buy
2022-08-02 Ripresa Canaccord Genuity Buy
2022-06-15 Iniziato Cantor Fitzgerald Overweight
2021-09-08 Iniziato ROTH Capital Buy
2021-05-27 Iniziato Oppenheimer Outperform
2021-05-25 Iniziato H.C. Wainwright Buy
Mostra tutto

Rezolute Inc Borsa (RZLT) Ultime notizie

pulisher
07:54 AM

Despite Recent Gains, Rezolute Insiders Are Still Down US$77k - simplywall.st

07:54 AM
pulisher
02:31 AM

Brokerages Set Rezolute, Inc. (NASDAQ:RZLT) PT at $24.38 - Defense World

02:31 AM
pulisher
Apr 02, 2025

Charles Schwab Investment Management Inc. Purchases 9,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Rezolute Director Makes Bold Stock Purchase - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Rezolute director Hogenhuis purchases $19,733 in common shares - Investing.com

Apr 01, 2025
pulisher
Mar 31, 2025

rezolute CEO Elam Nevan buys $34,999 in common shares By Investing.com - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

rezolute CEO Elam Nevan buys $34,999 in common shares - Investing.com

Mar 31, 2025
pulisher
Mar 28, 2025

Rezolute’s CFO Makes Bold Move with Major Stock Purchase! - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Rezolute Appoints Erik Harris to Board of Directors - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Rezolute CFO Daron Evans acquires $57,700 in common shares - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Rezolute Inc (NASDAQ: RZLT): Getting A Free Pass? - Stocks Register

Mar 28, 2025
pulisher
Mar 26, 2025

Rezolute expands board with biopharma veteran Erik Harris By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Rezolute expands board with biopharma veteran Erik Harris - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors - The Manila Times

Mar 26, 2025
pulisher
Mar 26, 2025

Strategic Move: Ultragenyx CCO Erik Harris to Drive Rezolute's Rare Disease Commercialization - Stock Titan

Mar 26, 2025
pulisher
Mar 24, 2025

Comparing Rezolute (NASDAQ:RZLT) & Akero Therapeutics (NASDAQ:AKRO) - Defense World

Mar 24, 2025
pulisher
Mar 12, 2025

Here's Why Rezolute (RZLT) Looks Ripe for Bottom Fishing - Nasdaq

Mar 12, 2025
pulisher
Mar 09, 2025

Analysts Set Rezolute, Inc. (NASDAQ:RZLT) Price Target at $24.38 - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

JMP Securities lifts Rezolute stock target to $9, maintains rating - MSN

Mar 07, 2025
pulisher
Mar 06, 2025

Rezolute, Inc. (NASDAQ:RZLT) Receives Average Rating of "Buy" from Analysts - MarketBeat

Mar 06, 2025
pulisher
Mar 05, 2025

A Guide To The Risks Of Investing In Rezolute Inc (RZLT) - Knox Daily

Mar 05, 2025
pulisher
Feb 22, 2025

Insider Buying: Wladimir Hogenhuis Acquires Additional Shares of Rezolute Inc (RZLT) - GuruFocus.com

Feb 22, 2025
pulisher
Feb 21, 2025

Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares By Investing.com - Investing.com Nigeria

Feb 21, 2025
pulisher
Feb 20, 2025

Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares - Investing.com India

Feb 20, 2025
pulisher
Feb 20, 2025

Hedge Fund and Insider Trading News: Scott Bessent, Warren Buffett, Stanley Druckenmiller, Tybourne Capital Management, Millennium Management, Rezolute Inc (RZLT), Rambus Inc (RMBS), and More - Insider Monkey

Feb 20, 2025
pulisher
Feb 20, 2025

Insider Trading Highlights: Wednesday's Key Moves in US Stocks - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Short Interest in Rezolute, Inc. (NASDAQ:RZLT) Rises By 17.4% - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

Rezolute director Kim Young-Jin buys $5 million in shares By Investing.com - Investing.com Australia

Feb 19, 2025
pulisher
Feb 19, 2025

Rezolute director Kim Young-Jin buys $5 million in shares - Investing.com

Feb 19, 2025
pulisher
Feb 18, 2025

Rezolute's SWOT analysis: biotech stock advances on ersodetug trials - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

Rezolute (NASDAQ:RZLT) Receives "Buy" Rating from HC Wainwright - MarketBeat

Feb 18, 2025
pulisher
Feb 18, 2025

JMP Securities Issues Positive Forecast for Rezolute (NASDAQ:RZLT) Stock Price - MarketBeat

Feb 18, 2025
pulisher
Feb 18, 2025

Rezolute: Late-Stage Study Targeting Hyperinsulinism (NASDAQ:RZLT) - Seeking Alpha

Feb 18, 2025
pulisher
Feb 17, 2025

Rezolute’s SWOT analysis: biotech stock advances on ersodetug trials By Investing.com - Investing.com Nigeria

Feb 17, 2025
pulisher
Feb 17, 2025

What is Wedbush’s Estimate for Rezolute FY2029 Earnings? - Defense World

Feb 17, 2025
pulisher
Feb 17, 2025

What is Wedbush's Estimate for Rezolute FY2029 Earnings? - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

What is HC Wainwright’s Estimate for Rezolute Q1 Earnings? - Defense World

Feb 17, 2025
pulisher
Feb 16, 2025

Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

Rezolute’s Strategic Advances in Rare Disease Therapies - MSN

Feb 16, 2025
pulisher
Feb 14, 2025

Guggenheim Reiterates Buy Rating for Rezolute (NASDAQ:RZLT) - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

JMP Securities lifts Rezolute stock target to $9, maintains rating By Investing.com - Investing.com Australia

Feb 13, 2025

Rezolute Inc Azioni (RZLT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):